The Food and Drug Administration has approved the first drug treatments for a deadly disease that causes severe lung damage. The agency on Wednesday approved two novel treatments from Boehringer Ingelheim and Roche for idiopathic pulmonary fibrosis.
Are you up for a challenge?
